Bestgen, B., Jones, S., Thathy, V., Kuemmerle, A., Barcelo, C., Haouala, A., Gossen, D., Marx, M. W., Di Resta, I., Szramowska, M., Webster, R. A., Llewellyn, S., Ritacco, D. A., Yeo, T., Leroy, D., Barber, B. E., Fidock, D. A., Griffin, P., Lickliter, J., & Chalon, S. (2024). Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(24)00664-9

Diawara, H., Healy, S. A., Mwakingwe-Omari, A., Issiaka, D., Diallo, A., Traore, S., Soumbounou, I. H., Gaoussou, S., Zaidi, I., Mahamar, A., Attaher, O., Fried, M., Wylie, B. J., Mohan, R., Doan, V., Doritchamou, J. Y. A., Dolo, A., Morrison, R. D., Wang, J., … Manoj, A. (2024). Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(24)00360-8

Naidoo, K., Perumal, R., Cox, H., Mathema, B., Loveday, M., Ismail, N., Omar, S. V., Georghiou, S. B., Daftary, A., O’Donnell, M., & Ndjeka, N. (2024). The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(24)00144-0

Rosenthal, P. J., Asua, V., Bailey, J. A., Conrad, M. D., Ishengoma, D. S., Kamya, M. R., Rasmussen, C., Tadesse, F. G., Uwimana, A., & Fidock, D. A. (2024). The emergence of artemisinin partial resistance in Africa: how do we respond? The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(24)00141-5

Mok, S., & Fidock, D. A. (2024). Determinants of piperaquine-resistant malaria in South America. The Lancet Infectious Diseases, 24(2), 114–116. https://doi.org/10.1016/s1473-3099(23)00564-9

van der Plas, J. L., Kuiper, V. P., Bagchus, W. M., Bödding, M., Yalkinoglu, Ö., Tappert, A., Seitzinger, A., Spangenberg, T., Bezuidenhout, D., Wilkins, J., Oeuvray, C., Dhingra, S. K., Thathy, V., Fidock, D. A., Smidt, L. C. A., Roozen, G. V. T., Koopman, J. P. R., Lamers, O. A. C., Sijtsma, J., … Khandelwal, A. (2023). Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands. The Lancet Infectious Diseases, 23(10), 1164–1174. https://doi.org/10.1016/s1473-3099(23)00212-8

Commons, R. J., Rajasekhar, M., Edler, P., Abreha, T., Awab, G. R., Baird, J. K., Barber, B. E., Chu, C. S., Cui, L., Daher, A., Gonzalez-Ceron, L., Grigg, M. J., Hwang, J., Karunajeewa, H., Lacerda, M. V. G., Ladeia-Andrade, S., Lidia, K., Llanos-Cuentas, A., Longley, R. J., … Woyessa, A. (2024). Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. The Lancet Infectious Diseases, 24(2), 172–183. https://doi.org/10.1016/s1473-3099(23)00430-9

Rajasekhar, M., Simpson, J. A., Ley, B., Edler, P., Chu, C. S., Abreha, T., Awab, G. R., Baird, J. K., Bancone, G., Barber, B. E., Grigg, M. J., Hwang, J., Karunajeewa, H., Lacerda, M. V. G., Ladeia-Andrade, S., Llanos-Cuentas, A., Pukrittayakamee, S., Rijal, K. R., Saravu, K., … Woyessa, A. (2024). Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis. The Lancet Infectious Diseases, 24(2), 184–195. https://doi.org/10.1016/s1473-3099(23)00431-0

Hazra, A., Zucker, J., Bell, E., Flores, J., Gordon, L., Mitjà, O., Suñer, C., Lemaignen, A., Jamard, S., Nozza, S., Nori, A. V., Pérez-Barragán, E., Rodríguez-Aldama, J. C., Blanco, J. L., Delaugerre, C., Turner, D., Fuertes, I., Leiro, V., Walmsley, S. L., … Marchetta, L. (2023). Mpox in people with past infection or a complete vaccination course: a global case series. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(23)00492-9

Barber, B. E., Fernandez, M., Patel, H. B., Barcelo, C., Woolley, S. D., Patel, H., Llewellyn, S., Abd-Rahman, A. N., Sharma, S., Jain, M., Ghoghari, A., Di Resta, I., Fuchs, A., Deni, I., Yeo, T., Mok, S., Fidock, D. A., Chalon, S., Möhrle, J. J., … Kansagra, K. (2022). Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study. The Lancet Infectious Diseases, 22(6), 879–890. https://doi.org/10.1016/s1473-3099(21)00679-4

Dhana, A., Hamada, Y., Kengne, A. P., Kerkhoff, A. D., Rangaka, M. X., Kredo, T., Baddeley, A., Miller, C., Singh, S., Hanifa, Y., Grant, A. D., Fielding, K., Affolabi, D., Merle, C. S., Wachinou, A. P., Yoon, C., Cattamanchi, A., Hoffmann, C. J., Martinson, N., … Maartens, G. (2022). Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. The Lancet Infectious Diseases, 22(4), 507–518. https://doi.org/10.1016/s1473-3099(21)00387-x

Eckhardt, C. M., & O’Donnell, M. R. (2022). CD24Fc: an emerging COVID-19 therapy. The Lancet Infectious Diseases, 22(5), 565–567. https://doi.org/10.1016/s1473-3099(22)00125-6

Ledesma, J. R., Ma, J., Vongpradith, A., Maddison, E. R., Novotney, A., Biehl, M. H., LeGrand, K. E., Ross, J. M., Jahagirdar, D., Bryazka, D., Feldman, R., Abolhassani, H., Abosetugn, A. E., Abu-Gharbieh, E., Adebayo, O. M., Adnani, Q. E. S., Afzal, S., Ahinkorah, B. O., Ahmad, S. A., … Kyu, H. H. (2022). Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. The Lancet Infectious Diseases, 22(2), 222–241. https://doi.org/10.1016/s1473-3099(21)00449-7